Introduction
The use and misuse of benzodiazepines (BZD), as well as their risk for dependence, were and still are major health issues leading to numerous pharmacoepidemiological surveys (1±5). To our knowledge no pharmaco-epidemiological study on BZD consumption has ever been carried out in Lebanon or in the Middle East Area. In addition, despite state laws, purchasing BZD from drugstores in Lebanon is possible without a medical prescription.
We conducted this national community survey with two main objectives: to determine the prevalence of BZD consumption in Lebanon, and to explore the risk factors for BZD use and dependence.
Material and methods
A two-stage process has been used to obtain two samples of community subjects. A randomized sample of 1000 subjects (sample 1) of the Lebanese population aged 18 years and above was drawn randomly at different degrees, strati®ed by area and proportional to the known structure in age and sex from the population of each area.
Sample 2 was constituted with 96 current BZD users (at least one intake in the past month) from sample 1, and by another sample of 400 subjects (drawn randomly from the Lebanese population following the same steps as for the ®rst sample, and retained on the basis of a past-month use of BZD).
We have estimated the prevalence rate of BZD consumption using the ®rst sample of 1000 subjects, whereas sample 2 was used to study risk factors for past-month BZD consumption and BZD dependence. Odds ratios (OR) were calculated by comparison with the 904 subjects from sample 1 who were not BZD recent users.
A 54-item questionnaire was elaborated for the study and performed through direct interview by trained students, assessing BZD use and dependence, various sociodemographic variables and life events.
Statistical analysis included univariate analysis of BZD use and dependence, and then a logistic regression for the multivariate analysis taking into account various sociodemographic and clinical variables, computing OR. The programs used were EP1±INFO version 6 and STATA.
Results

Benzodiazepine consumption
Subjects in sample 1 were 480 males and 520 females, with a mean age 39.6 years (SD=16.4; range: 18±95). The prevalence rate for BZD consumption during the month that preceded the survey was 9.6% (6.8% in males, and 12.1% in females). Approximately onethird (30%) took BZD for more than 12 months. Physicians (other than psychiatrists) accounted for 78% of the prescriptions, psychiatrists 11%, pharmacists, relative's or friend's advice and personal medication 11%.
Risk factors were analysed in sample 2, including 496 subjects (141 males and 355 females) with a BZD consumption during the past month. Numerous variables appeared to be associated with BZD consumption ( 
Dependence
In sample 2, the prevalence rate for BZD dependence (based on DSM-IV de®nition except the criteria on withdrawal symptoms) was 50.2% (50.3% in males and 50.1% in females). A persistent desire to stop or an unsuccessful stopping of the medication was found in 75.8% of the subjects (n=376). The prevalence of dependence was highest in the 45±64-year age group (56.7%). In the multivariate analysis, only two variables had a signi®cant impact on BZD dependence: use of other psychotropic agents (OR=3.18; 95% CI=1.85±5.49; P<0.0001), and existence of a life event (OR=1.98; 95% CI= 1.32±2.98; P=0.001).
Discussion
The past-month prevalence rate for BZD consumption in Lebanon was 9.6%, close to that reported for other countries (1, 2, 6) and even higher than the prevalence rate in other studies (3, 4) . We are comparing our national results to those of countries or major cities in western Europe, where access to medical services is easier and the social security system is more functional than in Lebanon. Hence, such a prevalence rate is extremely high for our country, where prevalence rates for anxiety disorders do not seem to be higher than in other populations (7) .
Signi®cant risk factors for BZD consumption in this study were female sex, age, cigarette smoking and life events. Age and sex are well-known associated factors in other surveys (1, 8) , but the two other factors are more unusual and might be linked to social stress of the war or of the post-war period, or to other culturally bound factors.
Benzodiazepine dependence rate was 50.2% in past-month users, and this rate is relatively high when compared to other studies (9). The existence of high levels of BZD consumption (9.6%) and dependence (one-half of current users) can be concluded from this national community survey. A better application of state laws concerning the delivery of BZD and a state regulation of the prescription are necessary but not suf®cient. The education of physicians and mainly non-psychiatrists to avoid misdiagnosing mood disorders and to be aware of the risk factor pro®le of dependence is essential. Furthermore, public awareness campaign may also help reduce consumption without medical advice.
